HEADER LIGASE/LIGASE INHIBITOR 24-JAN-15 4XTU TITLE MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE TITLE 2 INHIBITOR (N-({[(1R,2S,3R,4R)-4-(6-AMINO-9H-PURIN-9-YL)-2,3- TITLE 3 DIHYDROXYCYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS,4S,6AR)-2- TITLE 4 OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL LIGASE/REPRESSOR BIRA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BIOTIN--ACETYL-COA-CARBOXYLASE LIGASE,BIOTIN-PROTEIN LIGASE, COMPND 5 BIRA PROTEIN; COMPND 6 EC: 6.3.4.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: BIRA, CH81_03124, CH82_03406, CH84_03412, CH85_03111, SOURCE 5 CH87_01691, CH88_02592, CO60_3782, ER17_17395, FF22_02902, SOURCE 6 FI98_01129, IQ38_01820, IQ39_01720, IQ40_01775, IQ41_01700, SOURCE 7 IQ42_01770, IQ43_01710, IQ44_01750, IQ45_01765, IQ46_01705, SOURCE 8 IQ47_01735, IQ48_01770, IU12_01860, IU13_01785, IU14_01730, SOURCE 9 IU16_01770, IU17_01745, IU18_01730, IU19_01775, IU20_01750, SOURCE 10 IU22_01755, IU23_01750, IU24_01735, IZ84_17515, JE53_17495, SOURCE 11 LJ70_17695, T209_01770; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: MACH I; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS BIOTIN-PROTEIN LIGASE, BISUBSTRATE INHIBITOR, LIGASE-LIGASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.DE LA MORA-REY,B.C.FINZEL REVDAT 5 27-SEP-23 4XTU 1 REMARK REVDAT 4 11-DEC-19 4XTU 1 REMARK REVDAT 3 22-NOV-17 4XTU 1 REMARK REVDAT 2 06-SEP-17 4XTU 1 REMARK REVDAT 1 13-JAN-16 4XTU 0 JRNL AUTH M.R.BOCKMAN,A.S.KALINDA,R.PETRELLI,T.DE LA MORA-REY, JRNL AUTH 2 D.TAWARI,F.LIU,D.SCHNAPPINGER,B.C.FINZEL,C.C.ALDRICH JRNL TITL MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH JRNL TITL 2 BISUBSTRATE INHIBITOR JRNL TITL 3 (N-({[(1R,2S,3R,4R)-4-(6-AMINO-9H-PURIN-9-YL)-2, JRNL TITL 4 3-DIHYDROXYCYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS,4S,6AR) JRNL TITL 5 -2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANAMIDE) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.R.BOCKMAN,A.S.KALINDA,R.PETRELLI,T.DE LA MORA-REY, REMARK 1 AUTH 2 D.TIWARI,F.LIU,S.DAWADI,M.NANDAKUMAR,K.Y.RHEE, REMARK 1 AUTH 3 D.SCHNAPPINGER,B.C.FINZEL,C.C.ALDRICH REMARK 1 TITL TARGETING MYCOBACTERIUM TUBERCULOSIS BIOTIN PROTEIN LIGASE REMARK 1 TITL 2 (MTBPL) WITH NUCLEOSIDE-BASED BISUBSTRATE ADENYLATION REMARK 1 TITL 3 INHIBITORS. REMARK 1 REF J.MED.CHEM. 2015 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 26299766 REMARK 1 DOI 10.1021/ACS.JMEDCHEM.5B00719 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.355 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 60329 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.075 REMARK 3 FREE R VALUE TEST SET COUNT : 3062 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.3014 - 4.6204 0.99 2842 147 0.1622 0.2000 REMARK 3 2 4.6204 - 3.6685 0.99 2718 143 0.1442 0.1731 REMARK 3 3 3.6685 - 3.2051 0.99 2664 141 0.1677 0.1856 REMARK 3 4 3.2051 - 2.9122 0.99 2619 168 0.1746 0.1826 REMARK 3 5 2.9122 - 2.7035 0.98 2657 142 0.1846 0.2277 REMARK 3 6 2.7035 - 2.5442 0.99 2623 127 0.1891 0.2240 REMARK 3 7 2.5442 - 2.4168 0.98 2613 150 0.1830 0.2097 REMARK 3 8 2.4168 - 2.3116 0.98 2594 141 0.1910 0.2119 REMARK 3 9 2.3116 - 2.2226 0.98 2606 127 0.1866 0.2336 REMARK 3 10 2.2226 - 2.1459 0.98 2598 140 0.1916 0.2193 REMARK 3 11 2.1459 - 2.0788 0.98 2603 121 0.1976 0.2293 REMARK 3 12 2.0788 - 2.0194 0.98 2574 155 0.2041 0.2487 REMARK 3 13 2.0194 - 1.9663 0.98 2586 133 0.1985 0.2234 REMARK 3 14 1.9663 - 1.9183 0.98 2561 139 0.1989 0.2236 REMARK 3 15 1.9183 - 1.8747 0.98 2559 149 0.1976 0.2480 REMARK 3 16 1.8747 - 1.8348 0.97 2547 136 0.2122 0.2670 REMARK 3 17 1.8348 - 1.7981 0.98 2552 144 0.2047 0.2591 REMARK 3 18 1.7981 - 1.7642 0.97 2538 138 0.2161 0.2623 REMARK 3 19 1.7642 - 1.7327 0.97 2571 126 0.2196 0.2558 REMARK 3 20 1.7327 - 1.7033 0.97 2537 137 0.2138 0.2600 REMARK 3 21 1.7033 - 1.6758 0.97 2555 128 0.2173 0.2850 REMARK 3 22 1.6758 - 1.6500 0.96 2550 130 0.2305 0.2782 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.155 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.065 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.89 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4144 REMARK 3 ANGLE : 0.955 5673 REMARK 3 CHIRALITY : 0.033 670 REMARK 3 PLANARITY : 0.004 749 REMARK 3 DIHEDRAL : 13.248 1556 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XTU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000206144. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60393 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 115.282 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.40500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3RUX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17-24% PEG2000 MME, 100 MM TRIS, PH REMARK 280 8.5, 100 MM TRIETHYLAMINE N-OXIDE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.84200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.64100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.36750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.64100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.84200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.36750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 VAL B 1 REMARK 465 THR B 2 REMARK 465 ASP B 3 REMARK 465 PRO B 120 REMARK 465 PRO B 121 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 102 OD1 ASN A 130 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 130 22.28 -149.50 REMARK 500 ASN A 130 58.82 -159.88 REMARK 500 ALA A 147 87.89 -152.35 REMARK 500 VAL A 166 -48.42 -134.30 REMARK 500 ALA B 23 -95.30 -122.85 REMARK 500 VAL B 166 -48.19 -131.53 REMARK 500 ASP B 167 133.96 -170.08 REMARK 500 LEU B 208 -54.35 -157.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 614 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH B 646 DISTANCE = 6.04 ANGSTROMS REMARK 525 HOH B 667 DISTANCE = 6.33 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 44J A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 44J B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4XTV RELATED DB: PDB REMARK 900 RELATED ID: 4XTW RELATED DB: PDB REMARK 900 RELATED ID: 4XTX RELATED DB: PDB REMARK 900 RELATED ID: 4XTY RELATED DB: PDB REMARK 900 RELATED ID: 4XTZ RELATED DB: PDB REMARK 900 RELATED ID: 4XU0 RELATED DB: PDB REMARK 900 RELATED ID: 4XU1 RELATED DB: PDB REMARK 900 RELATED ID: 4XU2 RELATED DB: PDB REMARK 900 RELATED ID: 4XU3 RELATED DB: PDB DBREF1 4XTU A 2 266 UNP A0A045H8W3_MYCTX DBREF2 4XTU A A0A045H8W3 2 266 DBREF1 4XTU B 2 266 UNP A0A045H8W3_MYCTX DBREF2 4XTU B A0A045H8W3 2 266 SEQADV 4XTU GLY A -3 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU SER A -2 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU HIS A -1 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU MET A 0 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU VAL A 1 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU GLY B -3 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU SER B -2 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU HIS B -1 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU MET B 0 UNP A0A045H8W EXPRESSION TAG SEQADV 4XTU VAL B 1 UNP A0A045H8W EXPRESSION TAG SEQRES 1 A 270 GLY SER HIS MET VAL THR ASP ARG ASP ARG LEU ARG PRO SEQRES 2 A 270 PRO LEU ASP GLU ARG SER LEU ARG ASP GLN LEU ILE GLY SEQRES 3 A 270 ALA GLY SER GLY TRP ARG GLN LEU ASP VAL VAL ALA GLN SEQRES 4 A 270 THR GLY SER THR ASN ALA ASP LEU LEU ALA ARG ALA ALA SEQRES 5 A 270 SER GLY ALA ASP ILE ASP GLY VAL VAL LEU ILE ALA GLU SEQRES 6 A 270 HIS GLN THR ALA GLY ARG GLY ARG HIS GLY ARG GLY TRP SEQRES 7 A 270 ALA ALA THR ALA ARG ALA GLN ILE ILE LEU SER VAL GLY SEQRES 8 A 270 VAL ARG VAL VAL ASP VAL PRO VAL GLN ALA TRP GLY TRP SEQRES 9 A 270 LEU SER LEU ALA ALA GLY LEU ALA VAL LEU ASP SER VAL SEQRES 10 A 270 ALA PRO LEU ILE ALA VAL PRO PRO ALA GLU THR GLY LEU SEQRES 11 A 270 LYS TRP PRO ASN ASP VAL LEU ALA ARG GLY GLY LYS LEU SEQRES 12 A 270 ALA GLY ILE LEU ALA GLU VAL ALA GLN PRO PHE VAL VAL SEQRES 13 A 270 LEU GLY VAL GLY LEU ASN VAL THR GLN ALA PRO GLU GLU SEQRES 14 A 270 VAL ASP PRO ASP ALA THR SER LEU LEU ASP LEU GLY VAL SEQRES 15 A 270 ALA ALA PRO ASP ARG ASN ARG ILE ALA SER ARG LEU LEU SEQRES 16 A 270 ARG GLU LEU GLU ALA ARG ILE ILE GLN TRP ARG ASN ALA SEQRES 17 A 270 ASN PRO GLN LEU ALA ALA ASP TYR ARG ALA ARG SER LEU SEQRES 18 A 270 THR ILE GLY SER ARG VAL ARG VAL GLU LEU PRO GLY GLY SEQRES 19 A 270 GLN ASP VAL VAL GLY ILE ALA ARG ASP ILE ASP ASP GLN SEQRES 20 A 270 GLY ARG LEU CYS LEU ASP VAL GLY GLY ARG THR VAL VAL SEQRES 21 A 270 VAL SER ALA GLY ASP VAL VAL HIS LEU ARG SEQRES 1 B 270 GLY SER HIS MET VAL THR ASP ARG ASP ARG LEU ARG PRO SEQRES 2 B 270 PRO LEU ASP GLU ARG SER LEU ARG ASP GLN LEU ILE GLY SEQRES 3 B 270 ALA GLY SER GLY TRP ARG GLN LEU ASP VAL VAL ALA GLN SEQRES 4 B 270 THR GLY SER THR ASN ALA ASP LEU LEU ALA ARG ALA ALA SEQRES 5 B 270 SER GLY ALA ASP ILE ASP GLY VAL VAL LEU ILE ALA GLU SEQRES 6 B 270 HIS GLN THR ALA GLY ARG GLY ARG HIS GLY ARG GLY TRP SEQRES 7 B 270 ALA ALA THR ALA ARG ALA GLN ILE ILE LEU SER VAL GLY SEQRES 8 B 270 VAL ARG VAL VAL ASP VAL PRO VAL GLN ALA TRP GLY TRP SEQRES 9 B 270 LEU SER LEU ALA ALA GLY LEU ALA VAL LEU ASP SER VAL SEQRES 10 B 270 ALA PRO LEU ILE ALA VAL PRO PRO ALA GLU THR GLY LEU SEQRES 11 B 270 LYS TRP PRO ASN ASP VAL LEU ALA ARG GLY GLY LYS LEU SEQRES 12 B 270 ALA GLY ILE LEU ALA GLU VAL ALA GLN PRO PHE VAL VAL SEQRES 13 B 270 LEU GLY VAL GLY LEU ASN VAL THR GLN ALA PRO GLU GLU SEQRES 14 B 270 VAL ASP PRO ASP ALA THR SER LEU LEU ASP LEU GLY VAL SEQRES 15 B 270 ALA ALA PRO ASP ARG ASN ARG ILE ALA SER ARG LEU LEU SEQRES 16 B 270 ARG GLU LEU GLU ALA ARG ILE ILE GLN TRP ARG ASN ALA SEQRES 17 B 270 ASN PRO GLN LEU ALA ALA ASP TYR ARG ALA ARG SER LEU SEQRES 18 B 270 THR ILE GLY SER ARG VAL ARG VAL GLU LEU PRO GLY GLY SEQRES 19 B 270 GLN ASP VAL VAL GLY ILE ALA ARG ASP ILE ASP ASP GLN SEQRES 20 B 270 GLY ARG LEU CYS LEU ASP VAL GLY GLY ARG THR VAL VAL SEQRES 21 B 270 VAL SER ALA GLY ASP VAL VAL HIS LEU ARG HET 44J A 301 38 HET 44J B 301 38 HETNAM 44J N-({[(1R,2S,3R,4R)-4-(6-AMINO-9H-PURIN-9-YL)-2,3- HETNAM 2 44J DIHYDROXYCYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS,4S, HETNAM 3 44J 6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4- HETNAM 4 44J YL]PENTANAMIDE FORMUL 3 44J 2(C21 H31 N9 O6 S2) FORMUL 5 HOH *571(H2 O) HELIX 1 AA1 ASP A 3 ARG A 8 5 6 HELIX 2 AA2 ASP A 12 ILE A 21 1 10 HELIX 3 AA3 SER A 38 SER A 49 1 12 HELIX 4 AA4 ARG A 69 GLY A 71 5 3 HELIX 5 AA5 PRO A 94 ALA A 97 5 4 HELIX 6 AA6 TRP A 98 ALA A 114 1 17 HELIX 7 AA7 PRO A 115 ILE A 117 5 3 HELIX 8 AA8 ALA A 162 ASP A 167 1 6 HELIX 9 AA9 LEU A 173 GLY A 177 5 5 HELIX 10 AB1 ASP A 182 ASN A 203 1 22 HELIX 11 AB2 ASN A 205 ARG A 215 1 11 HELIX 12 AB3 ARG B 4 ARG B 8 5 5 HELIX 13 AB4 ASP B 12 ILE B 21 1 10 HELIX 14 AB5 SER B 38 GLY B 50 1 13 HELIX 15 AB6 ARG B 69 GLY B 71 5 3 HELIX 16 AB7 PRO B 94 TRP B 98 5 5 HELIX 17 AB8 GLY B 99 ALA B 114 1 16 HELIX 18 AB9 ALA B 162 ASP B 167 1 6 HELIX 19 AC1 ASP B 182 ASN B 203 1 22 HELIX 20 AC2 LEU B 208 ARG B 215 1 8 SHEET 1 AA1 7 GLN A 29 THR A 36 0 SHEET 2 AA1 7 VAL A 56 GLN A 63 1 O VAL A 57 N GLN A 29 SHEET 3 AA1 7 GLN A 81 ARG A 89 -1 O ILE A 83 N ALA A 60 SHEET 4 AA1 7 PHE A 150 ASN A 158 -1 O VAL A 155 N LEU A 84 SHEET 5 AA1 7 GLY A 137 ALA A 147 -1 N GLU A 145 O VAL A 152 SHEET 6 AA1 7 ASP A 131 ALA A 134 -1 N VAL A 132 O LEU A 139 SHEET 7 AA1 7 GLY A 125 LYS A 127 -1 N GLY A 125 O LEU A 133 SHEET 1 AA2 2 GLY A 66 ARG A 67 0 SHEET 2 AA2 2 GLY A 73 TRP A 74 -1 O TRP A 74 N GLY A 66 SHEET 1 AA310 ASP A 261 HIS A 264 0 SHEET 2 AA310 ARG A 222 GLU A 226 -1 N GLU A 226 O ASP A 261 SHEET 3 AA310 ASP A 232 ILE A 240 -1 O GLY A 235 N VAL A 223 SHEET 4 AA310 LEU A 246 VAL A 250 -1 O CYS A 247 N ASP A 239 SHEET 5 AA310 ARG A 253 VAL A 257 -1 O ARG A 253 N VAL A 250 SHEET 6 AA310 ARG B 253 VAL B 257 -1 O VAL B 256 N VAL A 256 SHEET 7 AA310 LEU B 246 VAL B 250 -1 N LEU B 248 O VAL B 255 SHEET 8 AA310 GLN B 231 ILE B 240 -1 N ASP B 239 O CYS B 247 SHEET 9 AA310 ARG B 222 LEU B 227 -1 N VAL B 223 O GLY B 235 SHEET 10 AA310 ASP B 261 HIS B 264 -1 O ASP B 261 N GLU B 226 SHEET 1 AA4 7 GLN B 29 THR B 36 0 SHEET 2 AA4 7 VAL B 56 GLN B 63 1 O ILE B 59 N VAL B 33 SHEET 3 AA4 7 GLN B 81 ARG B 89 -1 O ILE B 83 N ALA B 60 SHEET 4 AA4 7 PHE B 150 ASN B 158 -1 O VAL B 155 N LEU B 84 SHEET 5 AA4 7 GLY B 137 ALA B 147 -1 N GLU B 145 O VAL B 152 SHEET 6 AA4 7 ASP B 131 ALA B 134 -1 N VAL B 132 O LEU B 139 SHEET 7 AA4 7 GLY B 125 LYS B 127 -1 N GLY B 125 O LEU B 133 SHEET 1 AA5 2 GLY B 66 ARG B 67 0 SHEET 2 AA5 2 GLY B 73 TRP B 74 -1 O TRP B 74 N GLY B 66 CISPEP 1 TRP A 128 PRO A 129 0 3.25 CISPEP 2 GLN A 148 PRO A 149 0 0.67 CISPEP 3 TRP B 128 PRO B 129 0 -0.52 CISPEP 4 GLN B 148 PRO B 149 0 5.11 SITE 1 AC1 28 SER A 38 THR A 39 ASN A 40 GLN A 63 SITE 2 AC1 28 GLY A 66 ARG A 67 GLY A 68 ARG A 69 SITE 3 AC1 28 ARG A 72 GLY A 73 TRP A 74 ALA A 75 SITE 4 AC1 28 GLN A 81 ILE A 83 LEU A 84 ASN A 130 SITE 5 AC1 28 LYS A 138 GLY A 141 ILE A 142 VAL A 155 SITE 6 AC1 28 GLY A 156 ASN A 158 VAL A 166 ASP A 167 SITE 7 AC1 28 ALA A 170 HOH A 521 HOH A 526 HOH A 577 SITE 1 AC2 31 SER B 38 THR B 39 ASN B 40 GLN B 63 SITE 2 AC2 31 GLY B 66 ARG B 67 GLY B 68 ARG B 69 SITE 3 AC2 31 ARG B 72 GLY B 73 TRP B 74 ALA B 75 SITE 4 AC2 31 GLN B 81 ILE B 83 LEU B 84 ASN B 130 SITE 5 AC2 31 LYS B 138 GLY B 141 ILE B 142 LEU B 143 SITE 6 AC2 31 VAL B 155 GLY B 156 ASN B 158 VAL B 166 SITE 7 AC2 31 ASP B 167 ALA B 170 HOH B 443 HOH B 524 SITE 8 AC2 31 HOH B 532 HOH B 574 HOH B 612 CRYST1 63.684 68.735 115.282 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015703 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014549 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008674 0.00000